Ray G. Young - Archer Daniels Midland Co.
Management
Yeah, a significant part of the increase in terms of unallocated corporate on the management line is related to our investments in IT, the business transformation and R&D and innovation. We've indicated that these are – we view those as related investments. Although again from a GAAP perspective, we classify that as expense. But it's a fairly significant investment. I mean, as you are going to appreciate, one of our priorities is to improve our business processes. And so, we launched this program a couple years ago. And frankly, the run rate of spending as we head into 2017 is actually a fairly significant run rate right now in terms of investments. And so, I think, Rob, that this is actually a very, very important part in terms of our commitment, our investments, in terms of making this company better, particularly in the area of processes. In the area of innovation, frankly, for a company our size, we were under spending in terms of R&D and innovation. And I think what we're doing right now is actually devoting the more of our spending in that area. So WILD Flavors acquisition was actually very, very important because from that acquisition, we actually acquired a lot of innovation centers around the world. And that type of expense actually goes into this line called unallocated corporate as well. When you actually take a look at what I call core central staff costs, and when I say core, I mean this is excluding IT, excluding business transformation, excluding R&D. Our core central staff costs actually are still running at what we call the 2012 levels. I mean, if you recall back in 2012, we went through a restructuring of our central staffs. And so we've actually set our budgets and our cost plans based upon ensuring that our, what I call core central staffs, do not exceed the 2012 levels. And, so, I think it's important to kind of understand that in what I call like true corporate central staff cost, like the functions themselves, like accounting and HR, et cetera, et cetera, we've actually kept a lid on all those costs, where as we have we actually spent more money in terms what I call investments, particularly in business transformation, R&D and innovation. That's where we've seen the increase in. And we think that this is important for this company to make these types of investments at this point in time in order to allow us to be a better company in the future.
Robert Moskow - Credit Suisse Securities (USA) LLC: Thanks for the color Ray. And the $50 million in run-rate cost savings that you highlight; is that net of this incremental spending in any way or is it just kind of a separate metric?